Key objectives of pharmacovigilance in clinical trials include: Early identification of adverse drug reactions Continuous monitoring of benefit-risk balance Compliance with global regulatory requirements Protection of trial participants Supporting regulatory decision-making Effective pharmacovigilance systems ensure that safety concerns are detected promptly and that appropriate regulatory actions can be taken when necessary
To reduce this: Always rotate injection sites
GLP-1 medications improve insulin sensitivity and reduce visceral fat, hence, directly addressing the metabolic drivers of PCOS/PMOS, not just appetite
The liver produces IGF-1 (insulin-like growth factor-1) when stimulated by GH
Our nurses and medics are the best at what they do, and our clinic provides a clean, sterile, comfortable and safe environment
This includes individuals with diabetes (especially those on insulin or sulphonylureas), those with a history of pancreatitis, patients with liver disease, and anyone who has experienced severe gastrointestinal side effects with Wegovy
